e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
Paediatric year in review
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
What is in the air of a child with lung disease?
J. C. De Jongste (Rotterdam, The Netherlands)
Source:
Annual Congress 2005 - Paediatric year in review
Session:
Paediatric year in review
Session type:
Hot topics
Number:
205
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. C. De Jongste (Rotterdam, The Netherlands). What is in the air of a child with lung disease?. Annual Congress 2005 - Paediatric year in review
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Are inflammatory phenotypes in children with severe asthma stable?
Source: Annual Congress 2007 - Pathophysiology of childhood asthma: new insights
Year: 2007
Exhaled breath condensate (EBC): what is sampled and how should it be collected? (recommendations and open issues)
Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate
Year: 2007
Inflammatory phenotype of children with severe asthma
Source: Annual Congress 2007 - Pathophysiology of childhood asthma: new insights
Year: 2007
Use of exhaled nitric oxide measurements to guide treatment in chronic asthma
Source: Annual Congress 2006 - Scientific year in review
Year: 2006
Monitoring asthma and adjusting the inhaled steroid dose: is there a better way?
Source: Annual Congress 2005 - Are we ready for "inflammometry"? The role of eNO in asthma management
Year: 2005
Diagnosing asthma and prognostic significance of eNO
Source: Annual Congress 2005 - Are we ready for "inflammometry"? The role of eNO in asthma management
Year: 2005
Low exhaled nitric oxide levels in infants with respiratory symptoms in the first 2 months of life
Source: Annual Congress 2006 - Markers of paediatric airway disease
Year: 2006
The effect of montelukast on respiratory symptoms and lung function in wheezy infants
Source: Eur Respir J 2013; 41: 664-670
Year: 2013
Introduction
Source: Annual Congress 2005 - Are we ready for "inflammometry"? The role of eNO in asthma management
Year: 2005
A study of exhaled NO (FENO) measurement used to determine asthma control, dose of inhaled corticosteroid and cost in a developing country
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Longitudinal analysis between exhaled nitric oxide (FeNO), inflammatory markers (IM) in exhaled breath condensate (EBC), lung function, and control/severity of childhood asthma
Source: Annual Congress 2007 - Assessing asthma severity and control in children
Year: 2007
The effect of inhaled corticosteroid therapy on exhaled nitric oxide and exhaled hydrogen peroxide in asthma patients
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers
vs
induced sputum
Year: 2006
Effects of exacerbations and seasonality on exhaled nitric oxide in COPD
Source: Eur Respir J 2005; 26: 1009-1015
Year: 2005
Exhaled NO but not eosinophilic inflammation is reduced by inhaled corticosteroid treatment in COPD
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
Il-6 levels in exhaled breath condensate (EBC) of children with moderate well-controlled asthma stepping down inhaled corticosteroids
Source: International Congress 2017 – Diagnostic tools and comorbidities in paediatric asthma
Year: 2017
Exhaled nitric oxide in childhood asthma
Source: Annual Congress 2006 - Paediatric Respiratory Research Award
Year: 2006
High levels of fractional exhaled nitric oxide (FeNO) only reflect the degree of allergen sensitization in mild childhood asthma
Source: Annual Congress 2005 - Monitoring paediatric asthma
Year: 2005
The influence of smoking on the temperature of the exhaled air in patients with chronic lung diseases
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Outdoor swimming pools and the risks of asthma and allergies during adolescence
Source: Eur Respir J 2008; 32: 979-988
Year: 2008
Noninvasive assessment of airway inflammation in asthma
Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=164
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept